This document has been developed in partnership between the All Wales Medicines Procurement Pharmacist representing the Welsh Medicines Procurement and Logistics Advisory Group (WMPLAG) and ABPI Wales.
The Welsh Medicines Procurement and Logistics Advisory Group report to the All Wales Chief...
Saratha Rajeswaran has joined the Association of the British Pharmaceutical Industry (ABPI) [Start date: Tuesday 30 May] as the new Executive Director of Government Affairs and Devolved Nations.
Thanks to the Welsh Government’s £80 million New Treatment Fund, patients are benefiting from collaborative efforts to improve access to the very latest medicines, no matter where they live or what their disease.
The better you understand what’s heading your way, the better you can prepare and plan for the future. Identifying and planning for the availability of new innovative medicines and treatments in the pharmaceutical pipeline is no different.
After participating in The Independent Review of the Individual Patient Funding Request (IPFR) Process, ABPI Cymru Wales has responded to Vaughan Gething, AM, Cabinet Secretary for Health, Well-being and Sport and the Welsh Government’s statement on the review.
The Association of the British Pharmaceutical Industry (ABPI) has welcomed the Welsh Government’s ‘go-live’ of a £80 million New Treatment Fund aimed at speeding up Welsh NHS patient access to the very latest medicines.
The Association of the British Pharmaceutical Industry (ABPI) have issued the following statement on the calling of a snap General Election.
The ABPI Wales has today responded to a Welsh Government written statement on the publication of The Independent Review of the Individual Patient Funding Request (IPFR) Process.
As the Trade Association which represents the pharmaceutical companies who develop new innovative medicines, the ABPI strongly welcomes the announcement today of a New Treatment Fund in Wales by Vaughan Gething AM, Cabinet Secretary for Health Well-being and Sport.